Figure 2.
Relative mRNA expression levels of genes for sex steroid-metabolizing enzymes in abdominal subcutaneous and visceral AT. Results are presented as fold change. The black line represents the median. *P < .05; **P < .01, subcutaneous vs visceral AT (Wilcoxon signed-rank test, n = 12-13 for HT−, and 25-27 for HT+).
Abbreviations: CYP19A1, aromatase; HSD17B1, HSD17B2, HSD17B7, and HSD17B12, 17β-hydroxysteroid dehydrogenase 1, 2, 7, and 12; HT−, nonusers of HT; HT+, users of HT; STS, steroid sulfatase.
